论文部分内容阅读
目前我国对处方药药品采取“双轨制”的办法,即分期、分批公布必须凭处方购买的处方药并加强监管。目前,国家食品药品监督管理局已经列出了解除“双轨制”的时间表:2005年1月1日起,抗肿瘤药、激素类药品等处方药必须凭医生处方才能购买;2005年7月1日起,治疗神经系统疾病、心脑血管疾病、糖尿病及内分泌疾病的处方药必须凭医生处方才能购买;到2005年12月31日以后,实现全部处方药必须凭执业医师处方购买,在药师指导下使用。
At present, China adopts a “dual-track system” approach to prescription drug products, that is, to issue prescription drugs that must be purchased by prescription in stages and in batches, and to strengthen supervision. At present, the State Food and Drug Administration has listed the timetable for the lifting of the “dual track system”: Since January 1, 2005, prescription drugs such as anti-neoplastic drugs and hormone drugs must be prescribed by doctors before they can be purchased; July 1, 2005 From now on, prescription drugs for the treatment of diseases of the nervous system, cardiovascular and cerebrovascular diseases, diabetes and endocrine diseases must be purchased by doctor’s prescription; after December 31, 2005, all prescription drugs must be purchased on the prescription of a licensed physician and used under the direction of a pharmacist.